About Sun Pharma Laboratories Limited
Data last updated:
Sun Pharma Laboratories Limited is a public limited company based in Vadodara, Gujarat, India, a subsidiary of Sun Pharmaceutical Industries Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U25200GJ1997PLC133846. Its GSTIN is 24AACCS6163P1ZX (Gujarat). The company holds 54 GST registrations, of which 27 are active.
The company has an authorised share capital of ₹90 Cr and a paid-up capital of ₹40.05 Cr. It was formerly known as Sun Resins and Polymers Limited and Sun Resins and Polymers Private Limited. It is led by directors including Kirti Wardhaman Ganorkar (Whole-Time Director) and Priti Paras Savla.
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sun Pharma Advanced Research Centre (Sparc) Tandalja, Vadodara, Gujarat, India – 390012.
As per the financials filed for FY 2024, the company reported a revenue of ₹12,715 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹4,726.71 Cr (net margin 37.2%) and EBITDA of ₹5,850.03 Cr (EBITDA margin 46%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 22% over five years.
The company has about 1,968 employees on its provident fund (EPFO) records. Its group structure includes 4 subsidiaries.
Court records list 519 cases involving the company, including 430 filed by the company and 89 filed against it; 226 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹40.04 Cr; the latest was in August 2018. The company has 99 MSME Form 1 returns on record between 2014 and 2024, listing 3,758 overdue payments to 460 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunpharma.com.
Name History
Sun Pharma Laboratories has undergone 2 name changes throughout its history. The company was previously known as Sun Resins And Polymers Limited, and Sun Resins And Polymers Private Limited. The current legal name is Sun Pharma Laboratories Limited.
| Company Name | Status |
|---|---|
| Sun Pharma Laboratories Limited | Current |
| Sun Resins And Polymers Limited | Previous |
| Sun Resins And Polymers Private Limited | Previous |
CIN History
Sun Pharma Laboratories has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U25200GJ1997PLC133846, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U25200GJ1997PLC133846 | Current |
| U25200MH1997PLC240268 | Previous |
| U25200GJ1997PLC031527 | Previous |
| U25200GJ1997PTC031527 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressSun Pharma Advanced Research Centre (Sparc) Tandalja, Vadodara, Gujarat, India – 390012
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sun Pharma Laboratories Limited
FY 2025 filings availableSun Pharma Laboratories Limited reported revenue of ₹12,715 Cr (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 19% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | ₹12,715 Cr | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹5,850.03 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹4,726.71 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 46% | |
| Net Profit Margin | 37.2% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sun Pharma Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors and KMP of Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited currently reports 4 directors and 2 key managerial personnel. 22 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priti Paras Savla Also directs: Pitti Engineering Limited, Irb Infrastructure Developers Limited, Vikran Engineering Limited and 5 more | Director | 31 Oct 2022 | 3 Years 11 Months | Current |
| Meetal Sharad Sampat Also directs: Realstone Infra Limited | Company Secretary | 27 May 2022 | 4 Years 4 Months | Current |
| Rakeshchandra Jagdishprasad Sinha Also directs: Realstone Infra Limited, Zenotech Laboratories Limited, Caraco Pharmaceuticals Private Limited and 5 more | Director | 23 Apr 2024 | 2 Years 5 Months | Current |
| Kirti Wardhaman Ganorkar | Whole-Time Director | 21 May 2024 | 2 Years 5 Months | Current |
| Jayashree Satagopan Also directs: Ajax Engineering Limited, Skanray Technologies Limited | Cfo | 01 Jul 2025 | 1 Years 3 Months | Current |
| Gautam Bhailal Doshi Also directs: Bhavna Doshi Associates LLP, Sun Pharmaceutical Industries Limited, Piramal Finance Limited and 4 more | Director | 20 Oct 2021 | 5 Years 0 Months | Current |
Auditor Details
Sun Pharma Laboratories Limited is audited by SRBC & Co LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SRBC & Co LLP | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Sun Pharma Laboratories Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding
Sun Pharma Laboratories Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹40.04 Cr; the latest was in August 2018.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2018 | Secondary share transfer | Undisclosed | Seller: Sun Pharmaceutical Industries Limited |
| Mar 2013 | Secondary share transfer | Undisclosed | Seller: Sun Pharmaceutical Industries Limited |
| May 2012 | Funding round | ₹4.1 Lakh | Investors: Sun Pharmaceutical Industries Limited |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Sun Pharmaceutical Industries Limited Seller: an individual |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Sun Pharmaceutical Industries Limited , Sun Pharmaceutical Industries Limited & Dilip Shantilal Shanghvi, Sun Pharmaceutical Industries Limited & Ashok Bhuta Seller: Meghganga Finvest Private Limited , Shanghvi Finance Private Limited , Flamboyawer Finance Private Limited |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Sun Pharma Laboratories Limited has 519 court cases on record: 430 filed by Sun Pharma Laboratories, 89 filed against it. 226 cases are pending and 293 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 478 | 76 | 216 |
| District courts | 28 | 7 | 5 |
| Supreme Court | 13 | 6 | 5 |
Cases on record (5 of 519)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Consern Pharma Ltd. | Pending |
| Bombay High Court | Court case (CRR) | Filed by the company against Vridam Healthcare Private Limited and Ors. | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Consern Pharma Ltd. & Anr. | Pending |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays
Sun Pharma Laboratories Limited has 99 MSME Form 1 returns on record between 2014 and 2024, listing 3,758 overdue payments to 460 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 460)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Medigraph Pharmaceuticals Private Limited | •••• | •••• | •••• |
| Nupore Filtration Systems Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
: available in the company report
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance
Sun Pharma Laboratories Limited has a workforce of 1,968 employees as of Mar 27, 2025.
: available in the company report
Group Structure
Sun Pharma Laboratories has 4 subsidiary companies and 2 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Vivaldis Health And Foods Private Limited | U24297PN2014PTC150393 | Locked |
| Sun Pharmaceutical Medicare Limited | U36900GJ2017PLC095132 | Locked |
| Sun Pharma Distributors Limited | U51909MH2019PLC322778 | Locked |
| Realstone Infra Limited | U70109MH2020PLC337007 | Locked |
Showing major subsidiaries. Total: 4.
Recent Activity
Sun Pharma Laboratories Limited has 25 board changes on record since 2009: 6 appointments and 19 cessations. The latest: Chinnadharavaram Sundaresan Muralidharan ceased to be CFO on 01 Jul 2025.
16 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Sun Pharma Laboratories has 54 GST registrations: 27 active and 27 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCS6163P1ZX | Gujarat | Active | 01 Jul 2017 |
| 03AACCS6163P2Z0 | Punjab | Active | 01 Jul 2017 |
| 05AACCS6163P1ZX | Uttarakhand | Active | 01 Jul 2017 |
| 07AACCS6163P1ZT | Delhi | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Sun Pharma Laboratories is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 January 1997 (29+ years old) and is registered under CIN U25200GJ1997PLC133846.
Sun Pharma Laboratories has 6 current directors and KMP:
- Kirti Wardhaman Ganorkar - Whole-Time Director
- Priti Paras Savla - Director
- Rakeshchandra Jagdishprasad Sinha - Director
- Gautam Bhailal Doshi - Director
- Meetal Sharad Sampat - Company Secretary
- Jayashree Satagopan - Cfo
The latest financial statements of Sun Pharma Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sun Pharma Laboratories is 24AACCS6163P1ZX, registered in Gujarat. The company has 54 GST registrations in all, of which 27 are active and 27 are cancelled or inactive. Other active GSTINs include 03AACCS6163P2Z0 (Punjab), 05AACCS6163P1ZX (Uttarakhand), 07AACCS6163P1ZT (Delhi).
The CIN (Corporate Identification Number) of Sun Pharma Laboratories is U25200GJ1997PLC133846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sun Pharma Laboratories has 519 court cases on record: 430 filed by the company and 89 filed against it. 226 are pending. Most are in the high courts.
Sun Pharma Laboratories was incorporated on 17 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sun Pharma Laboratories has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹40.04 Cr; the latest was in August 2018.
Chinnadharavaram Sundaresan Muralidharan ceased to be CFO on 01 Jul 2025. Jayashree Satagopan was appointed as CFO on 01 Jul 2025. Rakeshchandra Jagdishprasad Sinha ceased to be Additional Director on 26 Aug 2024. Sun Pharma Laboratories has 25 board changes on record in total.
Sun Pharma Laboratories has 99 MSME Form 1 returns on record between 2014 and 2024, listing 3,758 overdue payments to 460 micro and small suppliers. The latest return was filed on 01 May 2024.
Sun Pharma Laboratories can be reached through the website sunpharma.com. Its registered office is in Vadodara, Gujarat, India.